Introduction Semaglutide, A medication initially developed for the treatment of type 2 diabetes, has emerged as a breakthrough in managing obesity and improving cardiovascular health. As a member of the GLP-1 receptor agonist class, Semaglutide mimics a natural hormone in the body that helps regulate blood sugar, suppress appetite, and https://socialbooks85183.eedblog.com/31640775/semaglutide-a-transformative-therapy-for-diabetes-obesity-and-heart-health